Toronto Marriott Markham Chosen to Host TED Conference Livestream

image004.jpg

Toronto, April 10, 2019 – The Toronto Marriott Markham is pleased to announce that it has been awarded the unique opportunity to livestream this year’s TED conference taking place in Vancouver, B.C. The award-winning hotel was among 12 Marriott properties globally selected to host a livestream event, and one of the two hotels in Canada to receive the honour. Guests and visitors to the hotel will be able to watch the conference at the property from April 15 to April 19.

The Toronto Marriott Markham will be livestreaming all twelve sessions starting on Monday April 15th at 8:00 pm. The main livestreaming site will be Draco Restaurant, the Marriott’s eatery specializing in delicious cocktails and locally inspired fare. The livestream event coincides with the one-year anniversary of the property, which opened its doors to significant fanfare in April of 2018.

The TED Conference brings together the world’s best thinkers and influencers in technology, science, finance, art, politics, and psychology to curate TED’s famous 18-minute talks. Notable speakers of TED 2019 include: Jack Dorsey (CEO and co-founder of Twitter and Square), Jon Chu (Director of the highly popular film Crazy Rich Asians), Adena Friedman (President and CEO of Nasdaq), and Joseph Gordon-Levitt (Actor, filmmaker and entrepreneur).

Members of the media and public are invited to join us at Draco for this rare opportunity to listen to some of the world’s best thinkers speak on today’s most relevant topics/issues. The full livestreaming schedule is as follows:

Monday April 15th

• Session 1: 8:00 pm – 10:00 pm

Tuesday April 16th

• Session 2: 11:45 am – 1:30 pm

• Session 3: 2:15 pm – 4:00 pm

• Session 4: 8:00 pm – 10:00 pm

Wednesday April 17th

• Session 5: 11:45 am – 1:30 pm

• Session 6: 2:15 pm – 4:00 pm

• Session 7: 8:00 pm – 10:00 pm

Thursday April 18th

• Session 8: 11:45 am – 1:30 pm

• Session 9: 2:15 pm – 4:00 pm

• Session 10: 5:30 pm – 7:00 pm

• Session 11: 8:00 pm – 10:00 pm

Friday April 19th

• Session 12: 12:00 pm – 2:30 pm

We hope to see you there! With Markham having such a strong business community especially in the world of high-tech and life sciences, and the great diversity found within the city, TED 2019 is sure to educate and inspire.

For more information on the Toronto Marriott Markham, visit https://www.marriott.com/hotels/travel/yyzmr-toronto-marriott-markham/

Jake Seguin

Logo

Jesson + Company Communications Inc.

77 Bloor St. W. Suite 1200

Toronto, On M5S 1M2

www.jessonco.com

P: 416 323-7828

F: 416-923 0226


You are receiving this correspondence because you have previously received emails from Jesson + Company Communications. To continue to receive electronic communications from Jesson + Company including: news, invitations, announcements and any other correspondence please click consent@jessonco.com to indicate we have expressed consent to contact you. You may withdraw consent at any time by clicking remove@jessonco.com

Livestream TED 2019 - Invite.PNG

Volunteering can make everyone's lives a little richer

NEWMARKET, ON, April 8, 2019 /CNW/ - "Volunteering makes me feel connected to something bigger than just myself," explained Tiffany Barker, board member and chair of the Client Services Committee at DeafBlind Ontario Services. 

Six years ago, when she was first approached about a board role, Tiffany admits she knew little about the deafblind community and the unique supports DeafBlind Ontario Services provides.

DeafBlind Ontario Services is a not-for-profit organization that helps individuals with deafblindness increase their independence and improve their quality of life through specialized services. Their volunteer board of directors, consisting of members like Tiffany, are responsible for providing strategic leadership, and ensuring the organization's mission, vision, and values are at the core of everything they do.

"I started learning more and was very excited to get involved. As a new board member, I had the honour of touring one of DeafBlind Ontario Services' locations… I will never forget that day! I was impressed by the individualized program plans and the breadth of planning that went into the accessible design of the house. As a nurse, I have been in many care facilities, but none has felt or looked like this one. It is truly a home." 

Tiffany also learned more about deafblindness, a combined loss of hearing and vision that impacts access to information, communication, as well as mobility. The number of individuals who are deafblind in Canada is 368, 412.[1] This number is based on prevalence estimates of 1% (average number based on all age groups) using Census 2016 population data. 

"At first, I was unaware of the important role that intervenors play in the lives of people with deafblindness," explained Tiffany.

Individuals with deafblindness have the capacity to build their life skills, gain independence and contribute to the greater community with the support of professional intervenors. The philosophy of DeafBlind Ontario Services' intervenors is "do with, not for". They work with people with deafblindness, helping them learn through experience, empowering them to make informed decisions and be active participants in all areas of their lives. 

"As I learned more about the work of the organization and got to know some of the employees and management team, I saw how committed and driven they are. I have learned a lot about how passion, innovative thinking, and diligence can lead to success."

A year after joining the board, Tiffany made the move out west to British Columbia. "Even though I was moving across the country, I requested to stay on the board of directors. Although I am geographically far, I haven't felt disconnected… video conferencing for meetings is great; it's nice to see people 'face-to-face'."

Volunteering is often seen as a selfless act; a person gives their time, skills, experience, and passion to help others, without expecting anything in return. And while volunteering is a form of service, many volunteers will tell you that "you get more than you give". "Giving to others is something that I strive to do and volunteering one's time is such an important way to give. It makes me feel happy and valued at the same time", said Tiffany.

"Being a nurse and working in the area of Public Health and Health Promotion, I care deeply about the work DeafBlind Ontario Services does to advocate, support, and enrich the lives of people with deafblindness. I relate to the values of the organization and recognize the importance of their work. Volunteering with DeafBlind Ontario Services is a good 'fit' for me."

"Our volunteers, like Tiffany, are so important to our entire team, especially to the people we support. Her dedication to the board and community-minded spirit are at the heart of what volunteerism is all about," said DeafBlind Ontario Services' Chief Executive Officer, Roxanna Spruyt-Rocks.

Tiffany is one of 12.7 million volunteers making a difference in Canada. This National Volunteer Week, April 7-13, join Volunteer Canada in celebrating and recognizing the contributions of volunteers in our communities. "It is important to contribute in big and small ways; together we can make everyone's lives a little richer," explained Tiffany.

For thirty years, DeafBlind Ontario Services has been enriching lives, one touch at a time for individuals with deafblindness. Since their beginning in 1989, they have made it their mission to inspire the spirit and determination of the people they support. To learn more about how you can make a difference, visit www.deafblindontario.com.

Website: www.deafblindontario.com     

Facebook: www.facebook.com/deafblindontarioservices  

Twitter: @DeafBlindON

Instagram: @DeafBlindON

__________________________________
1
 Open Your Eyes and Ears – To Estimates of Canadian Individuals with Deafblindness and Age-Related Dual Sensory Loss, 2018

SOURCE DeafBlind Ontario Services

APRIL IS ALCOHOL AWARENESSS MONTH 

ARE YOU REALLY A SOCIAL DRINKER OR COULD YOU BE AN ALCOHOLIC?

www.comprehendthemind.com

Increasingly, women are going head to head with men when it comes to binge drinking.   It’s not surprising: society normalizes, encourages, and promotes drinking so heavily that it can be nearly impossible, at times, to know what’s “normal” or not. A 2015 report by the National Institutes of Health, says an exploding number of Americans are in the drinking danger zone. According to the report, published in the journal JAMA Psychiatry, nearly one-third of American adults at some point in their life have an Alcohol Abuse Disorder, and only 20% seek treatment. Drinking may seem harmless but overindulging in alcohol is responsible for more than 80,000 deaths in this country per year and is the third leading cause of preventable deaths. We turned to NYC Neuropsychologist Dr. Sanam Hafeez  to outline the differences between social, problem and alcoholic drinking. 

Addicted alcoholics hide their habit

Dr. Sanam Hafeez says, “When people veer from social drinking to alcoholism, they usually try to conceal their drinking from those who are close to them. This is a warning sign because they deliberately wish to hide their drinking habit from their loved ones so as not to alarm or disappoint them. The fact is, the more they try to hide their drinking habit, the more serious their drinking problem becomes.”

Missing work

Alcoholics tend to miss work, damage other people’s lives, and not fulfill obligations because they stay busy drinking. Social drinkers will drink at specific times when they are usually free so that no important work is hampered. Social drinkers make sure that they do not over-drink, which ensures that they can tend to important obligations. “If they start ignoring these obligations because of drinking, they have likely become alcoholic,” says Dr.  Hafeez. 

You’re a weekend warrior.

“If you don’t drink daily, but are drinking regularly, such as binges every Friday night, that’s a red flag,” says Dr.  Hafeez. While research shows that having about seven alcoholic beverages per week lowers your risk of diabetes and cardiovascular disease, abstaining all week only to guzzle five or six glasses in a single sitting negates any of alcohol’s potential health benefits. Moreover, binge drinking can raise blood pressure and interfere with certain medications.

Drinking just “creeps up on you.”

Have you ever told yourself you were going to have only a drink or two at happy hour, and before you knew it you’d downed five? One of the clues that you may be a binge drinker is not knowing your limits—or feeling surprised when you've "suddenly" passed them. “Like diabetes, heart disease, and other health problems, drinking problems develop gradually and alcoholism is progressive,” says Dr.  Hafeez.

Drinking and driving

Alcoholics end up in alcohol-related accidents, while social drinkers do not. However, for a social drinker, they know that drinking and driving is not permitted and can be fatal. So, even if they over-drink on a particular social occasion, they don’t get behind the wheel.  

You wonder if there will be enough alcohol available 

“This most likely means that you are probably chasing the buzzed feeling and are unable to enjoy yourself without the fear of losing that high” says Dr. Sanam Hafeez. “It is most definitely a warning sign of addiction and it can be a sign of obsessive thinking around alcohol, which should absolutely raise red flags.”

You “Pre-Game It”

Perhaps you are going on a blind date and don’t want your date to think you drink too much so you have 2 drinks at home and 2 drinks while on the date. You know you’ve had 4 drinks, but your date perceives you as a “normal” drinker. You are aware of your true quantity and have the buzz to go along with it. 

You hide alcohol

If you don’t want your spouse, roommate or family member to see you drinking, perhaps you hide alcohol in a closet or bathroom cabinet and put your drinks in a colored paper cup so only you know you’re drinking. Dr. Sanam Hafeez says, “alcoholics will do this to be able to indulge in their addiction while attempting to “act sober” and deceive others around them.” 

You switch drinks or try to make rules for yourself that you don’t follow

Many people will negotiate with themselves. For example, “I will switch from 4 glasses of wine to two Vodkas” or “I will only drink on weekends,” “I will only go to happy hour when I have a new client win.”  “Normal” drinkers don’t make these kinds of bargains with themselves because their lives don’t revolve around alcohol or attempts to control consumption of it,” says Dr.  Hafeez.

A ”problem drinker” versus an alcoholic

Dr. Sanam Hafeez explains that, “A problem drinker is able to self-correct when they are given sufficient reason to do so – negative consequences, painful hangovers, birth of a child, new responsibilities, etc. An alcoholic, on the other hand, is unable to permanently cut back or stop drinking even when they have numerous reasons to do so. When faced with serious consequences and reality, an alcoholic may temporarily stop or limit themselves, but they will invariably return to their regular excessive drinking patterns.”

What to do if you’re not sure you have a problem 

Dr. Sanam Hafeez suggests, “If you are not certain you are an alcoholic, seek the advice of a therapist, or attend an AA meeting and speak with those who have long term sobriety to see if they share similar thoughts and experiences. If you feel that you need more than therapy to stop drinking, in patient treatment (rehab) may be the course of action you need to get both the therapy and tools to live a sober life. 

Sanam Hafeez Psy.D

New York State Licensed Neuropsychologist and School Psychologist 

www.comprehendthemind.com

Dr. Sanam Hafeez is a New York City based Neuro-psychologist and School Psychologist.  She is also the founder and director of Comprehensive Consultation Psychological Services, P.C.  She is currently a teaching faculty member at Columbia University. Click here to see Dr. Hafeez on Dr.Oz: http://www.doctoroz.com/episode/do-smart-drugs-work-we-test-them-so-you-don-t-have?video_id=4518086514001

Dr. Hafeez graduated from Queens College, CUNY with a BA in psychology.  She then went on to earn her Master of Science in Psychology at Hofstra University.  Following that she stayed at Hofstra to receive her Doctor of Psychology (Psy.D.) She later completed her post-doctoral training in Neuropsychology and Developmental Pediatrics at Coney Island Hospital.

Dr. Hafeez’s provides neuropsychological educational and developmental evaluations in her practice.  She also works with children and adults who suffer from post traumatic stress disorder (PTSD), learning disabilities, autism, attention and memory problems, trauma and brain injury, abuse, childhood development and psychopathology (bipolar, schizophrenia, depression, anxiety, etc…) In addition, Dr. Hafeez serves as a medical expert and expert witness by providing full evaluations and witness testimony to law firms and courts.

Dr. Hafeez immigrated to the United States from Pakistan when she was twelve years old.  She is fluent in English, Urdu, Hindi and Punjabi (Pakistani and Indian languages.) She resides in Queens, New York with her husband and twin boys.

Honors and Publications:

April 2013                              Main Speaker at Learning Disabilities Awareness Conference, New York City at Baruch College, CUNY

“Evaluating and Accommodating Students with    

  Disabilities”

June 2008                             Appointment to the New York City 18-B panel Assigned Counsel Plan

                                                Appointed as a preferred and approved Neuropsychologist and Clinical Psychologist in the New York City Court System for low cost or pro bono criminal, civil and family law cases

January 2008                      CUNY Proficiency Exam Waiver Position Paper

                                                Hafeez, S. (2008)

Commissioned by CUNY to advocate for the Learning Disabled population and the bias of the CUNY Assessment. 

Research based paper presented to the Board of CUNY Student Disabilities to waive requirement. 

1998-2000                                                      Doctoral Fellowship, Hofstra University

*Awarded a stipend in exchange for a research assistant position with core faculty member

Clinical Experience:

Director and Founder February 2003-Present

Comprehensive Consultation Psychological Services                                

  • Provide quality monolingual and bilingual psychological, educational, neuropsychological and speech and language evaluations
  • Early Intervention, Pre-School and School Age Special Education Services
  • Awarded a competitive contract through bidding with the New York City Department of Education (NYC DOE)
  • Awarded an assessment and interpreting contract with Putnam-Westchester BOCES
  • Provide evaluations and services to college level students with educational disabilities
  • Also provide occupational and physical therapy evaluations as well as therapeutic services in all areas. 
  • Contract with school district and various agencies to provide evaluations and related services
  • Provide neuropsychological, psychological and forensic evaluations for legal purposes to individuals, law firms, agencies and courts

Teaching Experience:

Faculty Appointment September 2011-Present

Columbia University, Teacher’s College, New York, NY

PhD program in Psychology

  • Instruction of neuropsychological and cognitive testing measures (SB-5, WJ-III, WISC-IV, etc)
  • Supervision and training of graduate students for clinical testing at university clinic
CANNAISSEUR BRANDS LAUNCHES NEW CBD ESSENTIALS
 
“Therapy Designed by Nature” 
 
Topically Applied Farm-to-Skin CBD Products 
Featuring the Brand’s Award-Winning Flower LOS ANGELES, CALIF. (SUMMER 2019)—This season, Cannaisseur Brands is re-launching its topically applied terpene-rich CBD Essentials product line with new branding, logo and packaging. The brand was founded by CBD industry expert and advocate Aryn Sieber, who consults with physicians and patients nationwide on the responsible use and medicinal benefits of cannabis. Sieber became a sought-after professional leader in the industry after using cannabis during his own battle with Stage IV cancer. CBD Essentials topically applied products are lab-formulated, third-party tested, and batch numbered to ensure quality and consistency. All CBD Essentials products feature Sieber’s award-winning flower and meet the federal requirements of the 2018 Farm Bill, which mandates that all CBD-infused products are derived from dried Cannabis Sativa L. plant material that contain less than 0.3 percent THC to be legal in the United States.
 
“CBD Essentials is dedicated to developing the highest quality therapeutic cannabis-infused products available,” said Ayrn SieberFounder of Cannaisseur Brands. “Using premium CBD flower and select terpenes in our award-winning farm-to skin formulas, the products are designed to optimize and support personal health and well-being.”
 
Real-world testing has shown CBD to have antioxidant and anti-inflammatory properties and to act as an antibacterial, antitumoral and antimicrobial. Studies also have shown that CBD can balance oil production in the skin. Furthermore, because the human body’s endocannabinoid system (ECS) is critically responsible for the life cycle of basal skin cells, some treatments encourage the ECS with topically applied CBD in an effort to help regulate the production of healthy skin. (It is important to note that therapeutic statements for CBD products are not yet evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.)
 
CBD is non-psychoactive. Cannabinoids are chemical compounds found in the cannabis plant that act on cannabinoid receptors in cells in the human body that alter neurotransmitter release in the brain. Ligands or bonding molecules for these receptor proteins include endocannabinoids which are naturally produced in the body. Terpenes refer to a class of compounds found in nearly every plant species including cannabis. They have been shown to influence many biological activities—including reduction of inflammation, reduced sensitivity to pain, and reduced anxiety. Terpenes and cannabinoids share a common biochemical precursor, giving them the ability to bind with different biological substances in the body, including receptors and enzymes.
 
The Cannaisseur Brands Summer 2019 collection features six key products:
 
CBD Essentials Pain Cream—This body cream, formulated to offer pain relief for sore muscles, aching joints, and chronic skin conditions, won the Les Nouvelles Esthétiques & Spa “Best New Product” award in 2018. A therapeutic blend of premium CBD, select terpenes, and organic hydrators such as coconut oil and shea butter facilitate muscle rejuvenation and replenish moisture for dry skin conditions. The product uses 50 mg. per oz. of premium CBD. CBD Essentials Pain Relief Cream is available in Green Tea Cucumber and Natural in sizes 1.5 oz. at a retail price of $24; 3 oz. at a retail price of $80; and 6 oz. at a retail price of $160CBD Essentials Pain Cream is now offered in the same sizes in Extra-Strength at 100 mg. per oz.
 
CBD Essentials Salt Soak Concentrate—This therapeutic blend of immune-boosting, mineral-rich sea salts, combined with premium CBD and select terpenes was formulated to soothe sore muscles, reduce stress, and induce relaxation. This product won the Les Nouvelles Esthétiques & Spa “Best New Product” award in 2019. CBD Essentials Salt Soak is available in Green Tea Cucumber, Eucalyptus, Lavender and Natural in sizes 1 oz. at a retail price of $16; 3 oz. at a retail price of $40; 5 oz. at a retail price of $70; and 6 oz. at a retail price of $80.
 
CBD Essentials Body + Massage Oil—This product features organic coconut oil infused with premium CBD to reduce discomfort associated with muscle and joint inflammation. This non-greasy topically applied product helps to rejuvenate tired muscles and aching joints, enhancing recovery and relieving pain. It was formulated to be used for therapeutic and oncology massages, and has been shown help reduce inflammation associated with arthritis, fibromyalgia, tendonitis and psoriasis in hundreds of real-world test cases. Designed for all skin types, the CBD Essentials Body + Massage Oil also can improve dry skin, deeply hydrating for maximum benefit and long-lasting protection. CBD Essentials Body + Massage Oil is available in Green Tea Cucumber, Peppermint, Eucalyptus, Lavender and Natural in sizes 1 oz. at a retail price of $29; and 4 oz. spray at a retail price of $90.
 
CBD Essentials Massage Roll-On—This product features the same formulation of CBD Essentials Body + Massage Oil, in the convenience of a roll-on applicator. CBD Essentials Massage Roll-On is available in Green Tea Cucumber, Peppermint, Eucalyptus, Lavender and Natural in sizes 0.3 oz. at a retail price of $12; and 3 oz. at a retail price of $70.
 
CBD Essentials Transdermal Patch—This THC-free time-released product delivers 70 mg. of premium CBD via a 2.5 in. by 3.5 in. waterproof adhesive patch (so it can be worn in the shower and during a workout) and is effective for up to 36 hours. CBD Essentials Transdermal Patch is unscented and available at a retail price of $30.
 
CBD Essentials Lip Balm—The first lip balm launched by the brand, CBD Essentials Lip Balm is formulated to moisturize the lips from discomfort associated with dryness and deeply hydrate dry skin for maximum benefit and long-lasting protection. CBD Essentials Lip Balm is available in Tropical Punch, Grape, Coconut, Vanilla and Peppermint in 0.15 oz. at a retail price of $8.
 
CBD Essentials products are available at CannaisseurBrands.com and select spas, wellness centers and specialty retail outlets nationwide.### 
About Cannaisseur Brands
Cannaisseur Brands was launched by cannabis industry advocate Aryn Sieber,who consults with physicians nation-wide on the legal use of medical cannabis and CBD for their patients. Sieber became a sought-after professional leader in the CBD and medical cannabis industry after using medical cannabis and CBD during his own battle with Stage IV cancer. The topically applied products in the Cannaisseur Brand line are lab-formulated, third-party tested, and batch numbered to ensure quality and consistency. All products in the line feature the brand’s award-winning flower.

Veterans Suffering from Both Traumatic Brain Injuries and PTSD 

Find Relief with Accelerated Resolution Therapy

Tampa, Florida (April 5, 2019) – Veterans who suffered both traumatic brain injuries and post-traumatic stress disorder (PTSD) found relief from their trauma symptoms using Accelerated Resolution Therapy (ART) in an average of four sessions—and at about the same rate as those who did not have brain injuries, according to a recent study published inCounselling and Psychotherapy Research.  

The findings indicate that ART, an innovative and rapid treatment for psychological trauma, is a suitable treatment for a significant and growing population, veterans who are coping from the effects of brain injuries and PTSD, according to principal investigator, Kevin E. Kip, Ph.D., FAHA, a professor of epidemiology at the University of South Florida, College of Public Health. 

“This is a very challenging group because they have a concussion history and have experienced significant psychological trauma,” said Dr. Kip. “Yet this combination of conditions is also increasingly common. About 70 percent of veterans who we have been treated in the studies of ART have suffered a concussion at some point.”

The study also showed that Special Forces veterans who underwent ART for trauma experienced significant improvements in their symptoms. ART provides some desirable treatment advantages for Special Forces veterans. Specifically, unlike traditional talk therapy, clients treated with ART do not need to divulge  details of their traumatic experiences (verbally or in writing),  which makes ideally suited for processing of trauma details from classified operations that cannot be disclosed within session

ART is an innovative treatment that empowers clients to resolve traumatic memories through a combination of relaxation techniques and memory visualization. The treatment employs a series of horizontal eye movements to enable clients to effectively rewrite troubling memories. ART provides effective relief from the strong physical and emotional reactions associated with PTSD, trauma, anxiety, and depression.  

Since ART was developed in 2008 by Laney Rosenzweig, MS, LMFT, there have been six research studies completed and several more are in progress. These studies have produced more than 10 published papers about the therapy in scientific peer-reviewed journals including those written by researchers at the University of South Florida. The ART research conducted to date has been federally funded by the Department of Defense and is currently funded by the National Institutes of Health. In 2015, ART was been recognized as an evidence-based therapy by the SAMHSA National Registry of Evidence-Based Programs and Practices.

Restauranteur and entrepreneur Chris T. Sullivan formed and is funding ART International Training and Research, Inc., a nonprofit organization dedicated to making ART more widely available to individuals in need of professional help in order to ameliorate the devastating effects of PTSD and other psychological traumas. The nonprofit is headed by Executive Director Kelly Breeding and is headquartered in Tampa, Florida.

This year, the nonprofit is hosting more than 100 training sessions throughout the United States offering local clinicians an opportunity to be trained and certified in ART. More information on ART International’s training sessions can be found on their website at artherapyinternational.org.  

An abstract of Dr. Kevin Kip’s manuscript can be viewed at the following link: https://onlinelibrary.wiley.com/doi/abs/10.1002/capr.12210. To schedule an interview with Dr. Kevin Kip, ART International executive director Kelly Breeding, therapists who employ ART or clients who have benefitted from the treatment, contact Julie Scharper at jscharper@hillmanpr.com

Is an Aspirin A Day A Good Idea?

Fairleigh Dickinson University, April 4, 2019 –  For years, Americans have been told about the benefits of daily aspirin usage. Eighty-one milligrams of aspirin daily can be helpful in warding off a host of ailments in some patients, according to research. A quarter of all Americans use or have used aspirin on a daily basis at some point in their life due to a widespread campaign to promote its impact on heart health, over-the counter accessibility, and its perceived safety due to the name “baby aspirin.” 

The Fairleigh Dickinson University School of Pharmacy and Health Science’s National Health Survey finds 24 percent of adults nationwide are now or have taken baby aspirin on a daily basis. Among those who have not taken the pill daily, thirteen percent believe they will at some point in their lives. Most (81%) take aspirin at the recommendation of their doctor, and another 18 percent arrived at the decision without speaking with a health professional.

Over half of aspirin users take the pill for prevention purposes, as 56 percent do not report having a chronic disease or illness. Aspirin can be used as a primary prevention agent - to preclude disease(s) from occurring in the future, and a secondary prevention agent - to decrease risk of disease recurrence, in addition to other  usage indications. 

Polling data showed that those suffering from a chronic illness or disease were twice as likely than those without an illness to take baby aspirin (41% versus 18%). A racial divide exists in daily usage as well. A third (31%) of white respondents use the drug for primary prevention as compared with 14 percent of non-white respondents.  

Although daily baby aspirin usage can be used for a variety of reasons, the public believes heart protection is the primary reason. Seventy-eight percent reportedly take, have taken, or think they will take it at some point in their lives in order to help prevent heart disease. Another sixteen percent say taking baby aspirin is beneficial to one’s overall health. Even though the research indicates the drug can provide benefits in protecting against certain forms of cancer, only one percent say this is the reason they take or would consider taking the drug.

“In view of recent evidence published in the New England Journal of Medicine, as well as updated American College of Cardiology/American Heart Association Guidelines released on March 17, 2019, aspirin should not be used routinely for the primary prevention of cardiovascular disease. In many patients, the risk of bleeding may be similar or greater compared to the benefit of preventing a cardiovascular event,” said Dr. Anastasia Rivkin, Assistant Dean for Faculty and Professor of Pharmacy Practice at the FDU School of Pharmacy and Health Sciences. “Individual patient parameters, such as age, overall cardiovascular risk assessment, and other factors should be thoroughly discussed with the patient’s health care provider before considering aspirin to prevent heart disease.” 

“There is more data to support use of baby aspirin for colorectal cancer prevention than other types of cancer. The 2016 U.S. Preventive Services Task Force guidelines recommend low-dose aspirin to prevent colorectal cancer in patients who are also at risk for cardiovascular diseases and are not at increased risk for bleeding,” continued Rivkin. “Based on research, long-term aspirin use can result in up to a 40 percent reduction of colorectal cancer risk.  What we found in this survey is that the general public is not aware of aspirin benefits for cancer prevention.”

As with all drugs, complications can arise from daily baby aspirin use. The public has mixed views about the safety of baby aspirin, despite a fair degree of usage or planned usage. A quarter (27%) of Americans believe daily baby aspirin use only has health benefits, 40 percent believe it can also hurt someone’s overall health, while a third (32%) remain unsure.

“Eighty-one milligram baby aspirin has both benefits and risks associated with daily use. The assumption that aspirin only has health benefits is incorrect. One meta-analysis published in the Annals of Internal Medicine and the U.S. Preventive Services Task Force which showed daily or every other day baby aspirin use increased risk of major gastrointestinal bleeding and hemorrhagic stroke, especially with increasing age and among men. Before this medication is recommended to a patient, healthcare providers decide whether the primary prevention benefits outweigh the risk of bleeding. The answer to this question will vary widely from one patient to another,” noted Dr. ElifÖzdener, Assistant Professor of Pharmacy Practice. 

References for data: https://www.uspreventiveservicestaskforce.org/Page/Document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer

Methodology –  The National Health Survey was conducted by The Fairleigh Dickinson University Poll on behalf of the FDU School of Pharmacy and Health Sciences. A random sample was drawn of adults nationwide, including in Alaska and Hawaii, and interviews were conducted on landlines and cellphones between January 28 - February 13, 2019. Respondents were screened in order to interview an adult, 18 or older. 

A total of 1000 interviews were administered by ReconMR in San Marcos, Texas. 296 interviews were conducted on landlines and 704 were conducted on cellphones by professionally trained interviewers using a CATI (Computer Assisted Telephone Interviewing) system. All interviews were conducted in English. Telephone numbers were purchased by ReconMR through Marketing Systems Group. 

Results for the total sample have a margin of sampling error of +/- 4.03 percentage points, including the design effect. 

Survey results are also subject to non-sampling error. This kind of error, which cannot be measured, arises from a number of factors including, but not limited to, non-response (eligible individuals refusing to be interviewed), question wording, the order in which questions are asked, and variations among interviewers. 

Weighting was applied to the sample to more accurately treat the respondents are representatives of the total population of the United States. 2019 estimates of the U.S. population by Claritas were used to weight the data. In this case, the proportions of three characteristics were used; Race, Age and Gender.  Each respondent falls into one, and only one, set and no respondent is left out.

Image

For the second year, the FDU Poll received an “A” rating from statistician Nate Silver’s FiveThirtyEight blog. The ratings measure both accuracy and bias for all major polling services in the United States, providing an update to similar research the poll watchers conducted in 2014. FDU’s “A” rating puts it in the top 15 of the more than 380 polling institutes reviewed and graded from A+ through F. The FDU poll was found to have a 94 percent accuracy rate for predicting election results, and is one of only three A-rated polling institutes with zero bias to their rankings. 

Tables

Are you now, or have you ever, taken baby aspirin on a daily basis?

1 Yes     24% 

2 No     76% 

8 DK (vol)    0

9 Refused (vol)    0

Image
Image

Did a doctor recommend that you take a baby aspirin on a daily basis? [N = 238]

1 Yes     81% 

2 No     19% 

8 DK (vol)    0

9 Refused (vol)    0 

Image
Image

Do you think you will ever take baby aspirin on a daily basis? [N = 762] 

1 Yes     13%

2 No     80%

8 DK (vol)    7%  

9 Refused (vol)    1%

Image
Image

At what age did you begin taking baby aspirin on a daily basis? [At what age do you think you should begin taking baby aspirin?] [N = 300]

Average age   54

Image
Image

Which of the following health concerns best describes why you would take [would consider taking] baby aspirin on a daily basis? [N = 336]

1 Heart protection    78%

2 Cancer prevention   1%

3 Good for overall health   16%

8 DK (vol)    4%

9 Refused (vol)    1% 

Image
Image

To the best of your knowledge, does daily baby aspirin only enhance health, OR can baby aspirin also HURT someone’s overall health? 

1 Enhances health    28%    

2 Can hurt health    40%

8 DK (vol)    31%

9 Refused (vol)    1%

Image
Image

Question wording and order

ASP1 Are you now, or have you ever taken baby aspirin on a daily basis?

1 Yes  Ask ASP2

2 No  Ask ASP3

8 DK (vol) Ask ASP3

9 Refused (vol) Ask ASP3

ASP2 Did a doctor recommend that you take a baby aspirin on a daily basis?

1 Yes  Ask ASP4

2 No  Ask ASP4

8 DK (vol) Ask ASP4

9 Refused (vol) Ask ASP4

ASP3 Do you think you will ever take baby aspirin on a daily basis?

1 Yes  Ask ASP4

2 No  Ask ASP6

8 DK (vol) Ask ASP6

9 Refused (vol) Ask ASP6

ASP4 At what age did you begin taking baby aspirin on a daily basis? [At what age do you think you should begin taking baby aspirin?]

Enter age 

8 DK (vol) 

9 Refused (vol) 

ASP5 Which of the following health concerns best describes why you would take [would consider taking] baby aspirin on a daily basis? [rotate options]

1 Heart protection

2 Cancer prevention

3 Good for overall health

8 DK (vol

9 Refused (vol)

ASP6 To the best of your knowledge, does daily baby aspirin only enhance health, OR can baby aspirin also HURT someone’s overall health? [rotate options]

1 Enhances health

2 Can hurt health

8 DK (vol

9 Refused (vol)

Weighted Sample characteristics

 N (%)MoE
Male487 (49%)+/- 4
Female513 (51%)+/- 4
40 & <358 (38%)+/- 5
41-49120 (13%)+/- 9
50-59163 (18%)+/- 8
60-69149 (16%)+/- 8
70+142 (15%)+/- 8
Refused69 (7%)+/- 12
White569 (57%)+/- 4
Black105 (11%)+/- 10
Hispanic184 (18%)+/- 7
Other141 (14%)+/- 8
White569 (57%)+/- 4
Non-white431 (43%+/- 5

1

Carrot Rewards Further Expands Strategic Footprint

Popular Canadian wellness program partners with private sector and broadens its impact mission

TORONTO, April 4, 2019 /CNW/ - Carrot Rewards, Canada's most popular wellness app today announced a further significant expansion of its mission and partnerships, as it continues to nudge well over a million Canadians towards living healthier lives. 

Carrot is deepening its strategic private sector and NGO engagements in a growing effort to positively influence consumer behaviour. New partnerships with leading insurance and pharmaceutical firms are harnessing the unique engagement and power of this innovative platform to boost consumer education in important behavioural areas as diverse as road safety or respiratory health management. Some of Carrot's newest mission partners include Boehringer Ingelheim, The Lung Association and Onlia. 

At the same time, the popular app is rapidly broadening its public impact work into the critically important area of civic wellness. More specifically, a key new mission element of the Carrot platform will be to educate Canadians on key immigration topics such as newcomer integration, transition support and access to a wide range of resources, from language skills training to financial literacy tools for new Canadians. 

"Three short years into our accelerating journey, it is so rewarding for us all to see our relevance, recognition and impact spread in so many important directions," said Andreas Souvaliotis, Founder & CEO of Carrot Rewards. "We are changing lives for the better every day and we are constantly adding to our uniquely and proudly Canadian story."

Rodney Ghali, Assistant Cabinet Secretary at the Privy Council Office in the Government of Canada stated "I have had the pleasure of watching Carrot Rewards grow from an initial pilot project to an internationally recognized digital platform for promoting health. It represents a unique example of the power of innovative and authentic partnerships between the public and private sectors in our country."

About Carrot Rewards

Carrot Rewards is an AI-driven wellness app and brand engagement platform that leverages behavioural economics and nudge theory to motivate and reward users for making better lifestyle choices. Carrot maximizes appeal and engagement by offering users a choice of rewards from the most popular consumer loyalty programs - in Canada users can earn Aeroplan® Miles, SCENE® points, Petro-Points™, More Rewards® points, Drop points or RBC Rewards each time they interact with the app. 

With well over one million users in this country, Carrot was recognized as Canadian App of the Year by MobileSyrup, ranked by Bond Brand Loyalty as a Top 10 Canadian Loyalty Program in the Loyalty Report, named one of the Top Fastest Growing Companies by Canadian Business and Maclean's Magazine and was the most recent Global Innovation Award winner at the World Government Summit.

The Carrot Rewards platform was created in collaboration with Canadian government agencies, health NGOs and the private sector. 

For more information, please visit: www.carrotapp.com 
Twitter & Instagram: @carrot_rewards 
Facebook: /carrotrewards    

Available for Interviews: 
Andreas Souvaliotis, Founder and CEO, Carrot Rewards

SOURCE Carrot Insights

Chef Paula Shoyer Offers Five Passover Desserts So Good You Will Want to Make Year-round!

Florentine Bars Recipe excerpted from The New Passover Menu20 square bars or 32 triangles
Ingredients
1 cup confectioners' sugar3 large egg whiteszest of one large orange (or 2 teaspoons juice)1/4 cup dried cranberries, chopped into ¼ inch pieces1 1/3 cups sliced almonds (blanched or with skin)1 cup dark or white chocolate chipsvegetable oil for greasing pan
Preheat oven to 325°F
Grease a 9 X 13-inch pan with vegetable oil. Press in a piece of parchment paper large enough to cover the bottom and go an inch up the sides of the pan, making sure you press it into the corners. Grease the top of the parchment.
In a medium bowl, whisk together the confectioners' sugar, egg whites and orange zest. Use a silicone spatula to gently mix in nuts and chopped cranberries, being careful not to crush the nuts. Scoop into the pan and use the spatula or your hands to spread evenly in the bottom of the pan. The easiest way to do this is to push the batter into the edges and corners first and then fill in the middle. You will have a thin nut layer.
Bake 25 minutes, or until nuts are golden. Let cool one hour. Pull up the parchment to lift the bar out of the pan. Place another piece of parchment on top and then turn the bar over onto the new parchment. Peel off the bottom parchment. 
Melt the chocolate chips either over a double boiler or in the microwave oven in for 45 seconds, stir, melt another 30 seconds, stir and then for 15 seconds more, if needed, until melted. Use a spatula to spread the chocolate on the bottom of the bar. If desired, you can use a serrated knife to make lines in the chocolate to decorate it. Slide the parchment and bars onto a cookie sheet and place in the freezer for 30 minutes to firm up. 
Cut into squares, triangles or rectangular bars. Store in an airtight container in the fridge for up to five days or freeze for up to three months
Lemon Quinoa Cakewww.kosherbaker.comServes 12Prep Time: 20 minutes Bake Time: 15 minutes to cook quinoa, 65 minutes to bake cake Advance Prep: May be made 3 days in advance or frozen 
Cake¾ cup quinoa1½ cups waterCooking spray or 2 tablespoons oil2 tablespoons lemon zest, from 2-3 large lemons½ cup fresh lemon juice, from 2-3 large lemons4 large eggs1 teaspoon pure vanilla extract (or other vanilla if for Passover)¾ cup coconut oil1 ¼ cups sugar1 cup almond flour¼ cup coconut flour, plus 2-3 tablespoon to dust bundt pan2 teaspoons baking powder1 teaspoon baking soda½ teaspoon salt
Glaze (optional)1 cup confectioners' sugar
2 tablespoons fresh lemon juice (from 1-2 lemons)
Place the quinoa and water into a small saucepan and bring it to a boil over medium heat. Reduce the heat to low, cover the saucepan, and cook the quinoa for 15 to 18 minutes, or until all the liquid has been absorbed. Let sit for 5 minutes off the stove-top. The quinoa may be made 2 days in advance and stored in the fridge.
Preheat the oven to 350°F. Use cooking spray or oil to grease a 12-cup Bundt pan. Sprinkle 1 to 2 tablespoons coconut flour, or more if needed, over the entire greased pan and then shake the pan all around to cover and then tap out the excess.
Place the quinoa in the bowl of a food processor. Add the lemon zest and juice, eggs, vanilla, oil, sugar, almond flour, coconut flour, baking powder, baking soda and salt and process until the mixture is very smooth, about 2 minutes.
Pour the batter into the prepared Bundt pan and bake it for 1 hour, or longer, until a skewer inserted into the cake comes out clean.
Let the cake cool for 30 minutes and then remove it gently from the pan onto a wire cooling rack.
To make the glaze, place the confectioners' sugar into a bowl and add 1 tablespoon of lemon juice and whisk well. Add more juice, a teaspoon at a time, until you have a thick glaze. Drizzle or pour over the cake.

Chocolate Quinoa CakeRecipe excerpted from The Healthy Jewish KitchenServes 12 Prep Time: 20 minutesBake Time:15 minutes to cook quinoa, 50 minutes to bake cakeAdvance Prep: May be made 3 days in advance or frozenEquipment: Measuring cups and spoons, small saucepan with lid, 12-cup (2.8L) Bundt pan, food processor, medium microwave-safe bowl or double boiler, silicone spatula, wooden kebab skewer, wire cooling rack, large microwave-safe bowl, whisk
Cake¾ cup (130g) quinoa1½ cups (360ml) waterCooking spray2 tablespoons potato starch1/3 cup (80ml) orange juice (from 1 orange)4 large eggs2 teaspoons pure vanilla extract (or other vanilla if for Passover)¾ cup (180ml) coconut oil1½ cups (300g) sugar1 cup (80g) dark unsweetened cocoa2 teaspoons baking powder½ teaspoon salt2 ounces (55g) bittersweet chocolateFresh raspberries, for garnish (optional)
Glaze (Optional)5 ounces (140g) bittersweet chocolate1 tablespoon sunflower or safflower oil1 teaspoon pure vanilla extract (or other vanilla if for Passover)
Place the quinoa and water into a small saucepan and bring it to a boil over medium heat. Reduce the heat to low, cover the saucepan, and cook the quinoa for 15 minutes, or until all the liquid has been absorbed. Set the pan aside. The quinoa may be made 1 day in advance.
Preheat the oven to 350°F (180°C). Use cooking spray to grease a 12-cup (2.8L) Bundt pan. Sprinkle the potato starch over the greased pan and then shake the pan to remove any excess starch.
Place the quinoa in the bowl of a food processor. Add the orange juice, eggs, vanilla, oil, sugar, cocoa, baking powder, and salt and process until the mixture is very smooth.Melt the chocolate over a double boiler, or place in a medium microwave-safe bowl, and put in a microwave for 45 seconds, stirring and then heating the chocolate for another 30 seconds, until it is melted. Add the chocolate to the quinoa batter and process until well mixed. Pour the batter into the prepared Bundt pan and bake it for 50 minutes, or until a skewer inserted into the cake comes out clean.
Let the cake cool for 10 minutes and then remove it gently from the pan. Let it cool on a wire cooling rack.
To make the glaze, melt the chocolate in a large microwave-safe bowl in the microwave (see above) or over a double boiler. Add the oil and vanilla and whisk well. Let the glaze sit for 5 minutes and then whisk it again. Use a silicone spatula to spread the glaze all over the cake.Keto Chocolate Avocado Cakewww.thekosherbaker.comMakes one 8-inch round cake
Cake1 ½ cups almond flour¾ cup dark cocoa, plus 1 tablespoon for greasing pan¼ cup coconut flour*½ cup xylitol1 teaspoon baking powder1 teaspoon baking soda¼ teaspoon salt½ cup coconut cream, from canned coconut milk½ cup almond milk3 large eggs1 tablespoon coconut oil, plus 1 teaspoon for greasing pan1 teaspoon vanilla1 large ripe avocado
Ganache5 tablespoons boiling water½ cup dark cocoa¼ cup xylitol½ cup coconut cream 1 teaspoon vanilla
Preheat oven to 350°F. 
Grease an 8-inch round pan with 1 teaspoon coconut oil. Add 2 to 3 teaspoons cocoa and shake all around to dust the bottom and sides. Tap out excess. Set aside.
In a mixing bowl, whisk together the almond flour, cocoa, coconut flour, xylitol, baking powder, baking soda and salt.
Place the coconut cream, almond milk, eggs, coconut oil, vanilla and avocado into a food processor or blender and blend for two full minutes, scraping down the sides a few times, so that the mixture is completely smooth. 
Add the wet ingredients to the dry ingredients and whisk together. Use a silicone spatula to scrape the batter into the prepared pan and smooth the top. 
Bake for 30 to 35 minutes, or until a toothpick inserted comes out clean. Let cool for 10 minutes and the remove to a wire rack.
To prepare the ganache topping, place the cocoa and xylitol into a small bowl. Add the boiling water and whisk well. Add the coconut cream and vanilla and mix well. Spread all over the top of the cake.
*can be substituted with almond flourTriple Chocolate Biscottiwww.thekosherbaker.comYield: 24-36 cookies
Prep Time: 10 minutesCook Time: 44 minutesStorage: room temperature for 5 daysAdvanced Prep: May be frozen
Ingredients

4 ounces (115g) bittersweet chocolate, broken

into pieces

1 cup (200g) sugar

1/2 cup (120ml) vegetable oil

2 large eggs

3 tablespoons (40g) vanilla sugar

1/2 cup (40g) unsweetened cocoa

1 tablespoon potato starch

1 1/2 cups (180g) ground almonds

1/4 teaspoon salt

1 cup (170g) semi-sweet chocolate chipsPreparation DirectionsPreheat oven to 350°F (180°C)Line a jelly roll pan or cookie sheet with parchment paper.
Melt the chocolate using one of the methods described in the box below. Remove the chocolate from the heat source, add the sugar and oil, and whisk well. Add the eggs and mix. Add the vanilla sugar, cocoa, potato starch, ground almonds, and salt and mix well. Add the chocolate chips and mix to distribute them.
Divide the dough in half and shape into two loaves, each about 9 x 3 inches (23 x 7.5cm). Place both loaves on the lined jelly roll pan and bake for 30 minutes. Let the loaves cool for 10 minutes (do not turn off the oven). Cut each loaf crosswise into 3/4- to 1-inch-thick (2- to 2.5-cm) slices. 
Place the cookies, cut side up, on a parchment-covered cookie sheet (or the jelly roll pan again). Bake for another 14 minutes, or until the cookies are firm to the touch on the outside but still feel soft on the inside. Check them after 10 to 12 minutes so that you don't over-bake the cookies.
Let cool for 5 minutes on the pan and then slide the parchment and cookies onto a cooling rack to cool completely.

CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity

Accretive acquisition of Colorado-based clinic group bolsters Company’s US medical cannabis clinical roll-up strategy; adds 15,000 new patients

TORONTO, ON – April 4, 2019 – CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services across the cannabis value chain, today made its second acquisition announcement in 2019 as it has acquired the assets of Colorado-based medical cannabis clinic group Rae of Sunshine Health Services (“ROSH”) LLC, operating as “Relaxed Clarity”, effective immediately.  This follows the 2017 acquisition of Massachusetts-based Canna Care Docs, the largest multi-state cannabis clinic group in the US and the March 20, 2019 announcement of the agreement to acquire Arizona and Colorado-based MedEval LLC. CB2 continues to acquire clinics as part of its strategy to standardize the capture of clinically-validated patient efficacy data. This new acquisition will help expedite that process and will not only improve CB2’s financial metrics but advance the industry at-large.

Relaxed Clarity operates four clinics in Colorado including Denver, Colorado Springs, Pueblo and Broomfield.  The group was established in 2009 and provides comprehensive medical cannabis evaluations and educational support to approximately 15,000 patients each year.  In 2018, Relaxed Clarity recorded approximately US$1.1 million in revenue.

Terms of the acquisition

Under the terms of the acquisition, CB2 has acquired 100% of the assets of each of ROSH and its subsidiaries for a combination of cash and stock.  Total consideration consisted of a cash payment of US$200,000 and issuance of 500,000 common shares of the Company.  Share consideration was negotiated by the parties based on Company’s most recent financing price, led by Merida Capital.  Additionally, milestone incentive payments are in place relating to patient growth over the next 12 months and total up to US$100,000 in cash and up to a value of US$300,000 in common shares of the Company.

Subsequent share issuances will be based on the 30-day volume weighted average price of the Company’s shares prior to the date of issuance and all shares will be subject to a minimum hold period of four months plus 1 day from the date of each issuance.  

Update on 2019 Revenue and Patient Trajectory

“Based on 2018 revenue results of this acquisition, CB2 Insights is currently on track to achieve at least CA$12.2 million in revenue for 2019,” said Prad Sekar, CEO, CB2 Insights. “We have an active pipeline of acquisition targets and along with organic growth within our existing operations, we anticipate achieving our stated 2019 revenue goal of more than CA$20 million, for year-over-year growth of more than 80% compared to 2018.“

At the close of 2018, CB2 Insights was collecting clinically-validated evaluation data through its business units of approximately 65,000 patients annually.  As a result of this announcement, combined with the pending acquisition of MedEval LLC, the Company projects its annualized patient count to increase to approximately 80,000 patient evaluations on an annualized basis.

About CB2 Insights

CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare.  We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands.  Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry. 

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CB2’s filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding results following the acquisition of Relaxed Clarity including Relaxed Clarity’s expected revenue, contribution to financial performance and patient evaluations, and the opportunity to provide services and software to the U.S. cannabis industry.

Although CB2 has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are subject to inconsistent legislation and regulation; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and recreational-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CB2 disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CB2 does not assume any liability for disclosure relating to any other company mentioned herein. 

No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.

mdBriefCase Announces New VP of Sales to Inspire Partnership Development

TORONTO, April 3, 2019 /CNW/ - mdBriefCase Group Inc. (mdBriefCase), Canada's leading provider of online continuing medical education (CME), is excited to welcome Catherine Rice, VP of Sales, Canada – the newest addition to the rapidly expanding team.

Rice joins the company as it focuses on growth in Canada and abroad, and promises to inject a high dose of energy into its already impressive development of strong partnerships within the health education industry. "It is with great pleasure that I announce Catherine Rice as Canada's new VP Sales," says mdBriefCase CEO Jason Flowerday. "She's a passionate leader with deep industry insights, experience and relationships who will add tremendous expertise to our leadership team".

Since 2001, mdBriefCase has delivered interactive, peer-reviewed and evidence-based programs free of charge on its proprietary learning management system. It has since advanced its commitment to enhancing the quality of care in communities around the world through its expansion into Australia, the Middle East, Europe and Africa. Delivering content for over 250,000 healthcare professionals in over 20 countries, mdBriefCase is proud to welcome Rice during a time that brings even more opportunity for innovation in health education.

Catherine Rice has more than 24 years of Canadian industry experience with multiple senior leadership roles in Sales and Marketing.  She has worked for Roche, Novo Nordisk, Eli Lilly, and Janssen-Ortho. Experienced in leading multi-disciplinary teams, Rice excels in the development and implementation of complex strategic plans through a focus on critical thinking and decision-making, collaboration and inclusivity.

Rice's academic credentials include a BSc in Neuro-Psychology from Queen's University and an MBA from McMaster University. 

SOURCE mdBriefCase Group Inc.